United Healthcare: Epoetin Alfa Epbx

Epoetin alfa-epbx is a biosimilar to EpogenProcrit epoetin alfa an erythropoiesis-stimulating agent ESA. Design setting participants measurements.

Rx Item Retacrit Epoetin Alfa Epbx Injection Vial 4000 Ml Vial 10x1ml By Pfizer

If you have an allergy to epoetin alfa or any other part of epoetin alfa-epbx.

Epoetin alfa epbx. Intravenous Epoetin Alfa-epbx versus Epoetin Alfa for Treatment of Anemia in End-Stage Kidney Disease. Epoetin alfa-epbx may be used for patients on kidney dialysis or for those not on dialysis. Using one such algorithm we assessed the maintenance of hemoglobin levels in patients switched from epoetin alfa reference product Epogen to epoetin alfa-epbx RetacritTM.

We compare the safety of epoetin alfa-epbx versus epoetin alfa based on a pooled analysis of findings from 2 randomized double-blind comparative clinical studies and report new data for the long-term safety of epoetin alfa-epbx. The product contains the identical amino acid sequence of isolated natural erythropoietin. Support includes assistance for eligible uninsured and insured patients who cannot afford their out-of-pocket costs.

If the body does not produce enough red blood cells severe anemia can occur. During this time it is best to avoid driving operating heavy machinery or other activities that could cause a serious injury if a seizure occurs while you are performing them. Epoetin alfa-epbx is a 165-amino acid erythropoiesis-stimulating glycoprotein manufactured by recombinant DNA technology.

5 position alpha- numeric codes representing primarily items and nonphysician services that are not represented in the level I codes. This study was conducted to compare the safety and efficacy of intravenous epoetin alfa-epbx an epoetin alfa biosimilar to epoetin alfa in patients on hemodialysis with ESKD and anemia. Talk with the doctor.

It may be given to you for other reasons. Epoetin alfa-epbx injection causes the bone marrow to produce red blood cells. What do I need to tell my doctor BEFORE I take Epoetin Alfa-epbx.

Each 1 mL single-dose vial of 2000 3000 4000 10000 and 40000 Units of epoetin alfa-epbx injection contains 05 mg of phenylalanine. In this 24-week multicenter double-blind comparative efficacy and safety study 612 patients on. Uses of Epoetin Alfa-epbx.

Design setting participants measurements In this 24-week multicenter double-blind comparative efficacy and safety study 612 patients on. The product contains the identical amino acid sequence of isolated natural erythropoietin. Before prescribing RETACRIT to a patient with PKU consider the combined daily amount of phenylalanine from all sources including RETACRIT.

Epoetin alfa-epbx is a biosimilar to the reference product epoetin alfa. NYSEPFE today announced the United States US Food and Drug Administration FDA approved RETACRIT epoetin alfa-epbx a biosimilar to Epogen and Procrit epoetin alfa1 for all indications of the reference product. It has a molecular weight of approximately 30400 daltons and is produced in Chinese Hamster Ovary CHO cell line.

The product contains the identical amino acid sequence of isolated natural erythropoietin. Biosimilar Erythropoiesis-Stimulating Agent ESA Now Approved Across All Indications Pfizer Inc. To learn more call Pfizer enCompass to talk to an Access Counselor at 844 722-6672 or visit the Pfizer enCompass website.

It has a molecular weight of approximately 30400 daltons and is produced in Chinese Hamster Ovary CHO cell line. Each 1 mL single-dose vial of 2000 3000 4000 10000 and 40000 Units of epoetin alfa-epbx injection contains 05 mg of phenylalanine. Epoetin alfa-epbx is a 165-amino acid glycoprotein manufactured by recombinant DNA technology.

RETACRIT the First US. It is used to help avoid the need for blood transfusions. Fishbane S Singh B Kumbhat S Wisemandle WA Martin NE Clin J Am Soc Nephrol 2018 Aug 71381204-1214.

Pfizer enCompass is a resource available to patients on RETACRIT therapy. Background and objectives This study was conducted to compare the safety and efficacy of intravenous epoetin alfa-epbx an epoetin alfa biosimilar to epoetin alfa in patients on hemodialysis with ESKD and anemia. Epoetin alfa-epbx sometimes causes convulsions seizures especially during the first few months of treatment.

Epoetin alfa-epbx is a 165-amino acid erythropoiesis-stimulating glycoprotein manufactured by recombinant DNA technology. It is used to treat anemia. Discuss the risks and benefits of epoetin alfa-epbx with your doctor as this medication may rarely cause very serious possibly fatal side effects including blood clots heart attack stroke.

Code Description Injection epoetin alfa-epbx biosimilar retacrit for non-esrd use 1000 units Contains all text of procedure or modifier long descriptions. A biosimilar to US-licensed EpogenProcrit. RETACRIT epoetin alfa-epbx injection is a sterile preservative-free clear and colorless solution in single-dose vials available asUnit of SaleStrengthEach Single Unit of UseNDC 0069-1305-10Carton containing 10 vials2000 UnitsmLNDC 0069-1305-011 mL Single-dose vialNDC 0069-1306-10Carton containing 10 vials3000 UnitsmLNDC 0069-1306-011.

For patients with anemia undergoing hemodialysis erythropoiesis-stimulating agents ESAs are typically dosed via precise algorithms. Before prescribing RETACRIT single-dose vials to a patient with PKU consider the combined daily amount of. This often occurs in people with chronic kidney failure whose kidneys are not working properly.

As of 2013 this field contains the consumer.

Long Term Safety Of Epoetin Alfa Epbx For The Treatment Of Anemia In Eskd Pooled Analyses Of Randomized And Open Label Studies Kidney Medicine